Previous Next

2024-03-29

IL-41 in resistance to Kawasaki disease treatments

Hematology

In this study, researchers examined the importance of IL-41 in clinical parameters and treatment resistance in Kawasaki disease. A total of 93 children with the disease were included. Serum IL-41 levels were significantly increased in children resistant to Kawasaki disease treatments. Serum IL-41 levels were positively correlated with erythrocyte sedimentation rate, C-reactive protein and C-reactive protein/albumin ratio, but negatively correlated with albumin. Total number of fever days and neutrophil/lymphocyte ratio were independent predictors of resistance to intravenous immunoglobulin. 


Source(s) :
Yan Duan et al. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease. Int Immunopharmacol. 2023 Sep:122:110600. ;

Last press reviews


How are new therapies transforming the management of metastatic castration-resistant prostate cancer?

By Lila Rouland | Published on November 18, 2025 | 3 min read<br>

Treatment of prostate cancer with GnRH agonists: what is the real impact on quality of life?

By Lila Rouland | Published on November 17, 2025 | 3 min read<br>

Can the tumor transcriptomic profile predict immunotherapy efficacy?

By Lila Rouland | Published on November 14, 2025 | 2 min read<br>...